Steve Anderson, managing director of PHOENIX UK, has welcomed the publication of NHS England’s Long-Term Year Plan and renewed his call for the Government to…
Galderma selects PHOENIX in a new Reduced Wholesaler Model We are delighted to inform you that Galderma have selected PHOENIX in a new Reduced Wholesaler agreement…
Venclyxto® (venetoclax) available through PHOENIX Manufacturer ABBVIE has chosen PHOENIX as a distribution partner for its oncolytic treatment Venclyxto® (venetoclax) Products available: PIP…
PHOENIX have announced the next stage of its growth strategy in Northern Ireland with the acquisition of a significantly larger medicines distribution depot in Belfast. The…
With the Christmas and New Year period approaching, we would like to advise you of our opening and closing times for the Festive period, and…
GSK UK Pharmaceuticals are changing the distribution model for medicines from the current Direct to Pharmacy model to a Reduced Wholesaler model, from 1st November…
